Clinical Trials in Cleveland

Showing 5901-5920 of 19,775 trials

Safety and Activity Study of an Oral Medication to Treat Moderate to Severe Crohn's Disease

NCT00102921

The purpose of this research study is to investigate the effects of an investigational medication, called CCX282-B, on safety and on the some of the symptoms of Crohn's Disease in patients who are experiencing an active flare-up of moderate to severe Crohn's Disease.

Crohn Disease

Amgen70 participantsStarted Aug 2004

Los Angeles, California, United States • Golden, Colorado, United States • Littleton, Colorado, United States +11 more locations

COMPLETEDPhase 3< 1 mile

Changes in NT-proBNP, Safety, and Tolerability in HFpEF Patients With a WHF Event (HFpEF Decompensation) Who Have Been Stabilized and Initiated at the Time of or Within 30 Days Post-decompensation (PARAGLIDE-HF)

NCT03988634

The effect of sacubitril/valsartan vs. valsartan on changes in NT-proBNP, safety, and tolerability in HFpEF patients with a WHF event (HFpEF decompensation) who had been stabilized and initiated at the time of or within 30 days post-decompensation.

Heart Failure With Preserved Ejection Fraction (HFpEF)

Novartis Pharmaceuticals467 participantsStarted Jun 2019

Irvine, California, United States • Long Beach, California, United States • Los Angeles, California, United States +94 more locations

Safety and Activity Study of an Oral Medication to Treat Moderate to Severe Crohn's Disease

Changes in NT-proBNP, Safety, and Tolerability in HFpEF Patients With a WHF Event (HFpEF Decompensation) Who Have Been Stabilized and Initiated at the Time of or Within 30 Days Post-decompensation (PARAGLIDE-HF)

Find Trials by Condition in Cleveland

A Study of Increasing Strengths, Safety and Efficacy of Two Formulas of LEO 43204 on the Face or the Chest in Patients With Actinic Keratosis

Innoventric Trillium™ Stent Graft Early Feasibility Study (EFS)

MGD019 DART® Protein in Unresectable/Metastatic Cancer

LEO 90100 Compared With Calcipotriol Plus Betamethasone Dipropionate Ointment, LEO 90100 Vehicle and Ointment Vehicle in Subjects With Psoriasis Vulgaris

SCS as an Option for Chronic Low Back and/or Leg Pain Instead of Surgery

Effect of Calcipotriol Plus Hydrocortisone Ointment on the Adrenal Hormone Balance and Calcium Metabolism in Patients With Psoriasis Vulgaris on the Face and Skin Folds

Comparison of Two Medications Aimed at Slowing Aortic Root Enlargement in Individuals With Marfan Syndrome

Phase 2a to Evaluate PL-8177 in Subjects with Active Ulcerative Colitis (UC)

An Epidemiological Study to Assess Performance of Using Healthcare Tools to Understand Genital Herpes Simplex Virus-2 (HSV-2) in Patients ≥ 18 Years of Age in the United States and Europe.

A Study to Test the Effect of Different Doses of BI 1358894 and Quetiapine in People With Depression

Observational Study of Persistence on Bafiertam Treatment in Routine Clinical Practice

Development of a Health-Related Symptom Index for Participants With and Either Treated or Monitored for Anal High-Grade Squamous Intraepithelial Lesions

Study to Assess the Safety and Biological Activity of AMX0035 for the Treatment of Alzheimer's Disease

LEO 124249 Ointment in the Treatment of Alopecia Areata

Open Label Pharmacokinetic Study of SAR302503 in Subjects With Renal Impairment

T-DM1+Pertuzumab in Pre-OP Early-Stage HER2+ BRCA

"Prapela® SVS Incubator Pad for Apnea of Prematurity

A Study to Compare the Safety and Efficacy of an Aromatase Inhibitor in Combination With Lapatinib, Trastuzumab or Both for the Treatment of Hormone Receptor Positive, HER2+ Metastatic Breast Cancer